Bristol-Myers Squibb Company (BCBA:BMY)

Argentina flag Argentina · Delayed Price · Currency is ARS
20,250
-275 (-1.34%)
At close: Jul 29, 2025, 5:00 PM BRT
-1.34%
Market Cap123.94T
Revenue (ttm)51.12T
Net Income (ttm)5.82T
Shares Outn/a
EPS (ttm)2,865.68
PE Ratio21.31
Forward PE7.92
Dividend652.40 (3.22%)
Ex-Dividend DateJul 3, 2025
Volume6,330
Average Volume1,415
Open20,350
Previous Close20,525
Day's Range20,150 - 20,550
52-Week Range16,950 - 27,225
Betan/a
RSI53.11
Earnings DateJul 31, 2025

About BCBA:BMY

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthrit... [Read more]

Industry Pharmaceutical Preparations
Founded 1887
Employees 34,100
Stock Exchange Buenos Aires Stock Exchange
Ticker Symbol BMY
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.